Observations of a large Dent disease cohort

Kidney International

Volumn 90, Issue 2, 2016, Pages 430-439

  Blanchard, Anne ^a,b,c,d   Curis, Emmanuel ^a,e   Guyon Roger, Tiphaine ^f   Kahila, Diana ^c   Treard, Cyrielle ^c   Baudouin, Véronique ^d,g   Bérard, Etienne ^h   Champion, Gérard ⁱ   Cochat, Pierre ^j   Dubourg, Julie ^c   de la Faille, Renaud ^k   Devuyst, Olivier ^l,m   Deschenes, Georges ^d,g   Fischbach, Michel ⁿ   Harambat, Jérôme ^k   Houillier, Pascal ^a,c,d   Karras, Alexandre ^c   Knebelmann, Bertrand ^o   Lavocat, Marie Pierre ^p   Loirat, Chantal ^d,g   Merieau, Elodie ^q   Niaudet, Patrick ^a,d,p   Nobili, François ^r   Novo, Robert ^f   Salomon, Rémi ^a,d,p   Ulinski, Tim ^d,s   Jeunemaître, Xavier ^a,b,c,d   Vargas Poussou, Rosa ^b,c,d   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Pediatric Nephrology Unit   (France)

^e UMR S 1144   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ ANGERS UNIVERSITY HOSPITAL   (France)

^j HOSPICES CIVILS DE LYON   (France)

^k BORDEAUX UNIVERSITY HOSPITAL   (France)

^l CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^m UNIVERSITY OF ZURICH   (Switzerland)

ⁿ HÔPITAL DE HAUTEPIERRE   (France)

^o HÔPITAL NECKER ENFANTS MALADES   (France)

^p UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^q UNIVERSITY HOSPITAL OF TOURS   (France)

^r UNIVERSITY HOSPITAL OF BESANÇON   (France)

^s ARMAND TROUSSEAU HOSPITAL   (France)

more..

Author keywords

Dent disease; hypercalciuria hypokalemia; proteinuria; renal failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BICARBONATE; CALCIUM CARBONATE; CITRATE POTASSIUM; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDOMETACIN; MAGNESIUM; PHOSPHATE; POTASSIUM; RAMIPRIL; CHLORIDE CHANNEL; CLC-5 CHLORIDE CHANNEL; OCRL PROTEIN, HUMAN; PHOSPHATASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLCN5 GENE; COHORT ANALYSIS; CONTROLLED STUDY; DENT DISEASE; DENT DISEASE TYPE 1; DENT DISEASE TYPE 2; DISEASE COURSE; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERCALCIURIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; IN FRAME MUTATION; IN VITRO STUDY; KIDNEY CALCIFICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; NONSENSE MUTATION; OCRL GENE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SPLICE SITE MUTATION; YOUNG ADULT; AGE; BLOOD; COMPARATIVE STUDY; COMPLICATION; GENETIC ASSOCIATION STUDY; GENETICS; GENOTYPE; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; MUTATION; NEPHROLITHIASIS; PHENOTYPE; URINE; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CHLORIDE CHANNELS; GENETIC ASSOCIATION STUDIES; GENETIC DISEASES, X-LINKED; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCALCIURIA; HYPOPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUTATION; NEPHROLITHIASIS; PHENOTYPE; PHOSPHORIC MONOESTER HYDROLASES; PROTEINURIA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84992520094     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.04.022     Document Type: Article

References (43)

1. 1 Dent, C.E., Friedman, M., Hypercalcuric rickets associated with renal tubular damage. Arch Dis Child 39 (1964), 240–249.
2. 2 Frymoyer, P.A., Scheinman, S.J., Dunham, P.B., et al. X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325 (1991), 681–686.
3. 3 Bolino, A., Devoto, M., Enia, G., et al. Genetic mapping in the Xp11.2 region of a new form of X-linked hypophosphatemic rickets. Eur J Hum Genet 1 (1993), 269–279.
4. 4 Akuta, N., Lloyd, S.E., Igarashi, T., et al. Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int 52 (1997), 911–916.
5. 5 Bogdanovic, R., Draaken, M., Toromanovic, A., et al. A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatr Nephrol 25 (2010), 2363–2368.
6. 6 Dinour, D., Davidovitz, M., Levin-Iaina, N., et al. Truncating mutations in the chloride/proton ClC-5 antiporter gene in seven Jewish Israeli families with Dent's 1 disease. Nephron Clin Pract 112 (2009), c262–c267.
7. 7 Reinhart, S.C., Norden, A.G., Lapsley, M., et al. Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 5 (1995), 1451–1461.
8. 8 Wrong, O.M., Norden, A.G., Feest, T.G., Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87 (1994), 473–493.
9. 9 Fisher, S.E., van Bakel, I., Lloyd, S.E., et al. Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 29 (1995), 598–606.
10. 10 Mansour-Hendili, L., Blanchard, A., Pottier, N.L., et al. Mutation update of the Clcn5 gene responsible for dent disease 1. Hum Mutat 36 (2015), 743–752.
11. 11 Hichri, H., Rendu, J., Monnier, N., et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 32 (2011), 379–388.
12. 12 Hoopes, R.R. Jr., Shrimpton, A.E., Knohl, S.J., et al. Dent Disease with mutations in OCRL1. Am J Hum 76 (2005), 260–267.
13. 13 Devuyst, O., Thakker, R.V., Dent's disease. Orphanet J Rare Dis, 5, 2010, 28.
14. 14 Devuyst, O., Christie, P.T., Courtoy, P.J., et al. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum Mol Genet 8 (1999), 247–257.
15. 15 Okamoto, T., Tajima, T., Hirayama, T., et al. A patient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5. Eur J Pediatr 171 (2012), 401–404.
16. 16 Moulin, P., Igarashi, T., Van der Smissen, P., et al. Altered polarity and expression of H+-ATPase without ultrastructural changes in kidneys of Dent's disease patients. Kidney Int 63 (2003), 1285–1295.
17. 17 Norden, A.G., Scheinman, S.J., Deschodt-Lanckman, M.M., et al. Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases. Kidney Int 57 (2000), 240–249.
18. 18 Bonthuis, M., van Stralen, K.J., Verrina, E., et al. Use of national and international growth charts for studying height in European children: development of up-to-date European height-for-age charts. PLoS One, 7, 2012, e42506.
19. 19 Counahan, R., Chantler, C., Ghazali, S., et al. Estimation of glomerular filtration rate from plasma creatinine concentration in children. Arch Dis Child 51 (1976), 875–878.
20. 20 Hoste, L., Dubourg, L., Selistre, L., et al. A new equation to estimate the glomerular filtration rate in children, adolescents and young adults. Nephrol Dial Transplant 29 (2013), 1082–1091.
21. 21 Pottel, H., Hoste, L., Martens, F., A simple height-independent equation for estimating glomerular filtration rate in children. Pediatr Nephrol 27 (2012), 973–979.
22. 22 Schwartz, G.J., Haycock, G.B., Edelmann, C.M. Jr., et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58 (1976), 259–263.
23. 23 Levey, A.S., Stevens, L.A., Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55 (2010), 622–627.
24. 24 Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
25. 25 Sayer, J.A., Carr, G., Simmons, N.L., Calcium phosphate and calcium oxalate crystal handling is dependent upon CLC-5 expression in mouse collecting duct cells. Biochim Biophys Acta 1689 (2004), 83–90.
26. 26 Vaisbich, M.H., Henriques Ldos, S., Igarashi, T., et al. The long-term use of enalapril and hydrochlorothiazide in two novel mutations patients with Dent's disease type 1. J Bras Nefrol 34 (2012), 78–81.
27. 27 Blanchard, A., Vargas-Poussou, R., Peyrard, S., et al. Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial. Am J Kidney Dis 52 (2008), 1084–1095.
28. 28 Cebotaru, V., Kaul, S., Devuyst, O., et al. High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease. Kidney Int 68 (2005), 642–652.
29. 29 Devuyst, O., Jouret, F., Auzanneau, C., et al. Chloride channels and endocytosis: new insights from Dent's disease and ClC-5 knockout mice. Nephron Physiol 99 (2005), p69–p73.
30. 30 Cramer, M.T., Charlton, J.R., Fogo, A.B., et al. Expanding the phenotype of proteinuria in Dent disease. A case series. Pediatr Nephrol 29 (2014), 2051–2054.
31. 31 Frishberg, Y., Dinour, D., Belostotsky, R., et al. Dent's disease manifesting as focal glomerulosclerosis: Is it the tip of the iceberg?. Pediatr Nephrol 24 (2009), 2369–2373.
32. 32 Dickson, L.E., Wagner, M.C., Sandoval, R.M., et al. The proximal tubule and albuminuria: really!. J Am Soc Nephrol 25 (2014), 443–453.
33. 33 Anglani, F., Bernich, P., Tosetto, E., et al. Family history may be misleading in the diagnosis of Dent's disease. Urol Res 34 (2006), 61–63.
34. 34 Brakemeier, S., Si, H., Gollasch, M., et al. Dent's disease: identification of a novel mutation in the renal chloride channel CLCN5. Clin Nephrol 62 (2004), 387–390.
35. 35 Copelovitch, L., Nash, M.A., Kaplan, B.S., Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2 (2007), 914–918.
36. 36 Lloyd, S.E., Pearce, S.H., Fisher, S.E., et al. A common molecular basis for three inherited kidney stone diseases. Nature 379 (1996), 445–449.
37. 37 Takemura, T., Hino, S., Ikeda, M., et al. Identification of two novel mutations in the CLCN5 gene in Japanese patients with familial idiopathic low molecular weight proteinuria (Japanese Dent's disease). Am J Kidney Dis 37 (2001), 138–143.
38. 38 Ludwig, M., Utsch, B., Balluch, B., et al. Hypercalciuria in patients with CLCN5 mutations. Pediatr Nephrol 21 (2006), 1241–1250.
39. 39 Piwon, N., Gunther, W., Schwake, M., et al. ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408 (2000), 369–373.
40. 40 Luyckx, V.A., Leclercq, B., Dowland, L.K., et al. Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression. Proc Natl Acad Sci U S A 96 (1999), 12174–12179.
41. 41 Lourdel, S., Grand, T., Burgos, J., et al. ClC-5 mutations associated with Dent's disease: a major role of the dimer interface. Pflugers Arch 463 (2012), 247–256.
42. 42 Bokenkamp, A., Bockenhauer, D., Cheong, H.I., et al. Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 155 (2009), 94–99.
43. 43 Grand, T., Mordasini, D., L'Hoste, S., et al. Novel CLCN5 mutations in patients with Dent's disease result in altered ion currents or impaired exchanger processing. Kidney Int 76 (2009), 999–1005.